Use of continuous positive airway pressure (CPAP) in preterm neonates has traditionally been limited to between 5-8 cmH2O. In recent years, use of CPAP pressures ≥9 cmH2O is becoming more common in neonates with evolving chronic lung disease, in lieu of other non-invasive modes or invasive mechanical ventilation. A particular knowledge gap in the current literature is the choice of the level of pressure level when using High CPAP as a post-extubation support mode. In this study, we will comparatively evaluate the short-term impact of two different high CPAP pressures when used as a post-extubation support mode in preterm neonates.
Background: Use of continuous positive airway pressure (CPAP) in preterm neonates has traditionally been limited to between 5-8 cmH2O. In recent years, use of CPAP pressures ≥9 cmH2O is becoming more common in neonates with evolving chronic lung disease, in lieu of other non-invasive modes or invasive mechanical ventilation. However, there are limited data on the effectiveness and safety of this mode. A particular knowledge gap in the current literature is the choice of the level of pressure level when using High CPAP as a post-extubation support mode. While it could be argued that the initial High CPAP pressure post-extubation should be somewhat higher than the pre-extubation mean airway pressure (Paw), there remain concerns of potential complications as well as uncertainty around degree of leak and resulting effectiveness. On the other hand, a suboptimal post-extubation High CPAP level may lead to atelectasis and contribute towards extubation failure, potentially prolonging invasive ventilation and associated risks. As such, research towards identification of the optimal High CPAP level post-extubation from high invasive ventilation pressures is warranted. Objective: To comparatively evaluate the short-term impact of two different high CPAP pressures when used as a post-extubation support mode in preterm neonates. Hypothesis: We hypothesize that babies extubated from invasive mechanical ventilation with a mean Paw between 9-15 cmH2O will demonstrate better physiological and clinical parameters when using High CPAP+2 cmH2O vs equivalent CPAP levels. Methods: Design - This will be a prospective, single-centre, randomized cross-over study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
26
The level of continuous distending pressure (or positive end-expiratory pressure) chosen on CPAP
McMaster Children's Hospital
Hamilton, Ontario, Canada
Peak Edi
The peak electrical diaphragmatic activity - a surrogate for work of breathing to generate tidal volume
Time frame: 60 min following each CPAP level - assessed over 10 min
Minimum EDi
The minimum eelectrical diaphragmatic activity - a surrogate for work of breathing to maintain functional residual capacity
Time frame: 60 min following each CPAP level - assessed over 10 min
Regional cerebral perfusion
The cerebral tissue extraction of oxygen - determined by near infra-red spectroscopy
Time frame: 60 min following each CPAP level - assessed over 10 min
Pressure level - Ventilator
Pressure level as measured by the ventilator
Time frame: 60 min following each CPAP level - assessed over 10 min
Pressure level - Interface
Pressure level at measured at the nasal interface used to deliver CPAP
Time frame: 60 min following each CPAP level - assessed over 10 min
Work of breathing score
Using Silverman Scoring
Time frame: Over entire duration (70 min) at each CPAP level, assessed every 10 min
Heart Rate
From cardiorespiratory monitoring
Time frame: Over entire duration (70 min) at each CPAP level, assessed every 10 min
Respiratory Rate
From cardiorespiratory monitoring
Time frame: Over entire duration (70 min) at each CPAP level, assessed every 10 min
Transcutaneous CO2 level
From bedside transcutaneous CO2 monitoring
Time frame: Over entire duration (70 min) at each CPAP level, assessed every 10 min
FiO2 level
Fractional inspired oxygen level, as determined by clinical and inputted into ventilator
Time frame: Over entire duration (70 min) at each CPAP level, assessed every 10 min
Number of bradycardic episodes <80 bpm
as above
Time frame: Over entire duration (70 min) at each CPAP level
Proportion of duration with SpO2 <90%
duration of time where the patient's SpO2 is less than 90%
Time frame: Over entire duration (70 min) at each CPAP level
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.